Thursday, March 12, 2015

FDA Leans on Another Compound Pharmacy for Manufacturing Problems Ed Silverman Wall Street Journal

Once again, the FDA has taken a tough stance against a compound pharmacy with quality-control problems that led to product recalls and concerns over patient safety. more

No comments: